Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct;30(4):724-727.
doi: 10.3350/cmh.2024.0465. Epub 2024 Jul 3.

Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"

Cho-Rong Lee  1 , Sung-Gyoo Park  1
Affiliations
Editorial

Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"

Cho-Rong Lee et al. Clin Mol Hepatol. 2024 Oct.
No abstract available

Keywords: CIITA; Hepatitis B virus; MHC class II.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts of interest to declare.

Comment on

References

    1. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5:793–806. - PubMed
    1. León Machado JA, Steimle V. The MHC class II transactivator CIITA: Not (Quite) the odd-one-out anymore among NLR proteins. Int J Mol Sci. 2021;22:1074. - PMC - PubMed
    1. Xie XW, Mei MH, Liao WJ, Qian LH, Yu X, Fei R, et al. Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma. Int J Oncol. 2009;34:681–688. - PubMed
    1. Dezhbord M, Kim SH, Park S, Lee DR, Kim N, Won J, et al. Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction. Clin Mol Hepatol. 2024;30:539–560. - PMC - PubMed
    1. Sandhu PK, Buchkovich NJ. Human cytomegalovirus decreases major histocompatibility complex class II by regulating class II transactivator transcript levels in a myeloid cell line. J Virol. 2020;94:e01901-19. - PMC - PubMed

LinkOut - more resources